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Summary
Despite being a hallmark of hematopoietic stem cells
(HSCs), HSC self-renewal has never been quanti-
tatively assessed. Establishment of a clonal and
quantitative assay for HSC function permitted demon-
stration that adult mouse HSCs are significantly
heterogeneous in degree of multilineage repopulation
and that higher repopulating potential reflects higher
self-renewal activity. An HSC with high repopulating
potential could regenerate approximately 1000 HSCs,
whereas the repopulating activity of regenerated
HSCs on average was significantly reduced, indicat-
ing extensive but limited self-renewal capacity in
HSCs. Comparisons of wild-type mice with mutant
mice deficient in the signal adaptor molecule Lnk
showed that not only HSC numbers but also the self-
renewal capacity of some HSCs are markedly in-
creased when Lnk function is lost. Lnk appears to
control HSC numbers by negatively regulating HSC
self-renewal signaling.
Introduction
Stem cells have been heralded as limitless sources for
tissue or organ regeneration because of their self-
renewal capacity. However, self-renewal capacity has
never been quantified for any type of stem cell, includ-
ing hematopoietic stem cells (HSCs). Long-term multi-
lineage repopulating activity detectable by transplanta-
tion experiments is the most reliable HSC marker.
Based on competitive repopulation (Micklem et al.,
1972), repopulating units (RUs) (Harrison et al., 1993)
and competitive repopulating units (CRUs) (Szilvassy et
al., 1990) have been used to express stem cell activity
quantitatively (Figure 1). RUs indicate the amount of re-
populating activity and CRUs the number of stem cells;
these two units thus complement one another. Given
both RU and CRU values, the mean activity of stem
cells (MAS) can be calculated (MAS = RU/CRU). We*Correspondence: hema@ims.u-tokyo.ac.jp (H.E.); nakauchi@ims.
u-tokyo.ac.jp (H.N.)
3 These authors contributed equally to this work.have proposed use of MAS when stem cell qualities
are compared among different populations (Ema and
Nakauchi, 2000).
Evidence for self-renewal of HSCs has been provided
by retroviral marking studies in which HSC clones
tagged with retroviral integration sites were trans-
planted into secondary recipients (Dick et al., 1985; Kel-
ler et al., 1985; Keller and Snodgrass, 1990; Lemischka
et al., 1986). A high degree of HSC purification enabled
successful long-term reconstitution with single HSCs
(Ema et al., 2000; Osawa et al., 1996; Takano et al.,
2004). After transplantation of single CD34−/lowc-Kit+
Sca-1+lineage marker− (CD34−KSL) cells, we observed
emergence of donor-derived CD34−KSL cells in the re-
cipients’ bone marrow (BM), indicating self-renewal
and expansion of the originally transplanted single
CD34−KSL cells. However, when these cells were
sorted and transplanted into secondary recipients, the
reconstitution capacity of the CD34−KSL cells ap-
peared significantly diminished (H.N., unpublished
data). These data imply that while HSCs do self-renew
in BM of primary recipients, their capacity to self-
renew declines.
To examine this possibility, we needed to develop a
clonal and quantitative assay for self-renewal of HSCs
(Figure 1). First, single-cell-reconstituted mice were
created. BM cells of these mice then were analyzed for
RU and CRU produced by single donor cells. This let
us know the number of HSCs regenerated from single
HSCs and let us use the MAS of these regenerated
HSCs to evaluate their quality.
During our study, we encountered an interesting mu-
tant mouse lacking a signal adaptor molecule, Lnk. Lnk
shares with APS and SH2-B a pleckstrin homology do-
main, a Src homology 2 domain, and potential tyrosine
phosphorylation sites. It belongs to a family of adaptor
proteins implicated in integration and regulation of mul-
tiple signaling events (Ahmed and Pillay, 2003; Huang
et al., 1995; Li et al., 2000; Takaki et al., 1997; Yokouchi
et al., 1997). Lnk is expressed in a variety of hematopoi-
etic cell lineages, including CD34−KSL cells and
CD34+KSL cells (see Supplemental Figure S1 available
with this article online).
Lnk null mutation mice accumulate myeloid and
B-lymphoid precursor cells in adult BM and spleen; this
is ascribed to hypersensitivity to c-Kit ligand (KL) (Ta-
kaki et al., 2000; Velazquez et al., 2002). Lnk may act
as a negative regulator in the c-Kit signaling pathway
(Takaki et al., 2002). Unlike BM cells of various mutant
mice with a deficiency of a particular molecule and se-
verely disturbed early hematopoiesis (Bjornsson et al.,
2003; Kimura et al., 1998; Lessard and Sauvageau,
2003; Mikkola et al., 2003; Miller et al., 1996; Ohta et
al., 2002; Okuda et al., 2000; Park et al., 2003; Tsai et
al., 1994; Warren et al., 1994), BM cells of Lnk-deficient
mice are competitively superior in hematopoietic re-
population to those of wild-type mice (Takaki et al.,
2002). However, it was unclear whether the characteris-
tics and numbers of HSCs are altered in Lnk-deficient
mice. We therefore analyzed HSCs from wild-type mice
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908Figure 1. Experimental Design for Clonal and
Quantitative Evaluation of Self-Renewal
(A) A mouse is reconstituted with a single
HSC. BM cells isolated from this mouse are
transplanted into multiple mice.
(B and C) Upon secondary transplantation, a
population-type assay (B) and a limiting dilu-
tion-type assay (C), both based on competi-
tive repopulation (CR), are performed. The
number of RU in defined numbers of BM
cells (such as 106 cells) can be determined
from % chimerism obtained by FACS analy-
sis of peripheral blood cells (B). The number
of CRU in the BM can be calculated from the
frequency of CRU in defined numbers of BM
cells (C). The number of RU and the number
of CRU that 1 CRU regenerates in BM can
thus be estimated. The MAS, an average RU
per CRU, indicates the quality of regener-
ated CRU. Thus, RU, CRU, and MAS can be
used as parameters for measurement of self-
renewal activity in an individual HSC. Black
circles indicate CRUs. a, cells derived from
test cells; b, cells derived from competitor
cells; c, cells derived from a host mouse; d,
limiting dose of cells.as well as Lnk-deficient mice and quantitatively com- d
apared their self-renewal activity.
R
(Results
c
MRU and CRU in Bone Marrow
We first attempted quantitative comparison of HSC d
4activities in BM of wild-type C56BL/6 (B6) mice and of
Lnk-deficient B6 mice (Takaki et al., 2002) in terms of H
RU. One RU is defined as the amount of repopulating
activity in 105 BM cells from wild-type mice, based on
competitive repopulation assays (Harrison et al., 1993). P
WLnk-deficient mice had approximately 63 RU per 105
BM cells (Table 1). We then estimated the number of b
dHSCs by measuring the number of long-term marrow
repopulating cells as CRU. Limiting-dilution analysis re- C
tvealed that 105 BM cells from wild-type mice had 3.2
CRU on average (Figure 2 and Table 1), consistent with B
mour previous estimation (Sudo et al., 2000). In contrast,
Lnk-deficient mice of the same age had 52.6 CRU in b
f105 BM cells (Table 1 and Figure 2). Since total numbers
of BM cells did not differ significantly between these i
utwo kinds of mice, the absolute number of HSCs in Lnk- re 3B).
Table 1. Increases of RU and CRU in BM of Lnk-Deficient Mice
Mice BM cells (×107) RU/105 BM cells CRU/105 BM cells (95% CI) MAS (RU/cell)
WT B6 6.4 ± 1.2 (n = 8)* 1.0 3.2 (1.8–5.6) 0.3
Lnk KO B6 6.6 ± 1.9 (n = 5) 63.3 ± 33.2 (n = 5) 52.6 (31.3–83.3) 1.2
Wild-type (wt) and Lnk-deficient (Lnk-KO) B6 mice aged 8 weeks were compared. The numbers of bone marrow (BM) cells in the hindlimbs
(two femora and two tibiae) and RU per 105 BM cells are expressed as mean ± SD. CRU per 105 BM cells is expressed as mean (95%
confidence interval). Mean activity per stem cell (MAS) was calculated using the averages of RU and CRU. Asterisk indicates previously
published data (Sudo et al., 2000).eficient BM was clearly increased more than 16-fold
s compared with that in wild-type BM. The average
U per individual HSC, or mean activity of stem cells
MAS) (Ema and Nakauchi, 2000), in wild-type BM was
alculated as approximately 0.3 RU/cell (Table 1). The
AS value in Lnk-deficient BM was 1.2 RU/cell. Lnk-
eficient HSCs thus have, on average, approximately
-fold greater repopulating activity than do wild-type
SCs.
henotypically Defined HSC Populations
e next attempted to estimate the HSC pool size,
ased on HSC surface phenotypes and Hoechst 33342
ye efflux capacity. More than 10 times as many
D34−KSL cells as well as lineage marker−side-popula-
ion (Lin−SP) cells (Goodell et al., 1996) were found in
M of 8-week-old Lnk-deficient mice as in BM of age-
atched wild-type mice (Figure 3A). Interestingly, num-
ers of both CD34−KSL cells and Lin−SP cells in BM
rom femora and tibiae of Lnk-deficient mice started to
ncrease exponentially at around 4 weeks of age (Fig-
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Cell-cycle analysis was performed on 5000 or more
CD34−KSL cells isolated from 8-week-old wild-type or
Lnk-deficient mouse BM, stained with propidium iodide
(PI). More than 98% of the cells were in the G0/G1 phase
in both cases (Supplemental Figure S2A). To compare
the turnover rate of Lnk-deficient HSCs with that of
wild-type HSCs, mice were fed water containing bro-
modeoxyuridine (BrdU) for 2 weeks, and BrdU incorpo-
ration by CD34+KSL cells or CD34−KSL cells was ana-
lyzed (Supplemental Figure S2B). More than 95% of the
CD34+KSL cells isolated from either wild-type or Lnk-
deficient mice took up BrdU by 2 weeks. Consistent
with previous observations (Sudo et al., 2000), 76.3%
of the CD34−KSL cells from wild-type mice were la-
beled with BrdU by 2 weeks. In contrast, 94.6% of
those cells from Lnk-deficient mice were labeled. These
data suggest that Lnk-deficient HSCs enter the cell cy-
cle more frequently than do wild-type HSCs. However,Figure 2. Increased Frequency of HSCs in BM Cells of Lnk-Defi-
cient Mice
Graded numbers of BM cells from wild-type (wt) or Lnk-deficient
(Lnk-KO) mice were transplanted together with 2 × 105 competitor
cells. The frequency of CRUs in BM cells of Lnk-deficient or wild-
type mice was estimated to be one in 1,900 cells or one in 31,000
cells.lating activity of an individual HSC. This increased RU
Figure 3. Expansion of HSC Populations in
Lnk-Deficient Mice
(A) Representative FACS profiles show Sca-1
and c-Kit expression in CD34−Lin− BM cells
(top) and the SP in Lin− BM cells (bottom).
The proportions of CD34−KSL cells or Lin−SP
cells were remarkably increased in Lnk-defi-
cient mice (right) as compared with those in
wild-type mice (left). The percentages of
gated cells among total BM cells are shown.
(B) The kinetics of development of CD34−
KSL cells (top) or Lin−SP cells (bottom) are
shown, along with mouse age.the cell-cycling status at any one time remains un-
changed in CD34−KSL cells, presumably because of
their discontinuous cycling.
Single-Cell Reconstitution
As in wild-type mice, transplantation of 100 or more
CD34+KSL cells isolated from Lnk-deficient mice re-
sulted in little reconstitution (data not shown), indica-
tive of enrichment of HSCs in the CD34−fraction among
KSL BM cells of the mutant mice. Because numbers of
CD34−KSL cells and actual numbers of HSCs are
discrepant in aged normal mice (Sudo et al., 2000),
CD34−KSL cells in Lnk-deficient mice were subjected
to competitive repopulation. Single such cells isolated
from wild-type or Lnk-deficient mice were transplanted
into a total of 172 lethally irradiated mice, along with
2 × 105 competitor BM cells. Four months after trans-
plantation, multilineage reconstitution with more than
1% test donor chimerism in myeloid, B-lymphoid, and
T-lymphoid lineages was observed in 24 of 96 (25%)
mice and in 17 of 76 (22%) mice transplanted with sin-
gle CD34−KSL cells from wild-type and from Lnk-defi-
cient mice, respectively (Figure 4). Of note is that the
engraftment rates of CD34−KSL cells were similar in
these groups. Moreover, RU values varied widely
among HSCs of both wild-type and Lnk-deficient mice.
RU values in mice that received wild-type cells ranged
from 0.05 to 3.26 RU per cell, showing that HSCs are
extremely heterogeneous in myelolymphoid lineage-
reconstituting activity (Figure 4). RU values in mice that
received Lnk-deficient cells ranged from 0.06 to 14.4.
Lnk-deficient HSCs showed a wider range of RU and
therefore appeared more heterogeneous in terms of re-
populating ability. The average of RU/cell in repopulat-
ing cells, i.e., MAS by definition, from Lnk-deficient
mice was significantly greater than that from wild-type
mice (p < 0.05) (Figure 4). Consistent with data for un-
fractionated BM cells (Table 1), the MAS in Lnk-defi-
cient mice appeared to be 4.3-fold higher than that in
wild-type mice in this clonal analysis. These data indi-
cate that in this mutant mouse strain, not only the abso-
lute number of HSCs is increased, but also the repopu-
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910Figure 4. Multilineage Reconstitution by Single CD34−KSL Cells from Wild-Type or Lnk-Deficient Mice
A single CD34−KSL cell from wild-type (wt) or Lnk-deficient (Lnk KO) mice was mixed with 2 × 105 BM cells and transplanted into a lethally
irradiated mouse. All myeloid and B- and T-lymphoid lineages were reconstituted with a single test donor cell 4 months after transplantation
in 24 of 96 (25%) mice receiving wild-type cells and in 17 of 76 (22%) mice receiving Lnk-deficient cells.
(A) The list of RU per cell calculated based on % chimerism for each CRU. The MAS (2.76 ± 3.84, n = 17) in Lnk-deficient repopulating cells
was significantly higher than that (0.64 ± 0.80, n = 24) in wild-type repopulating cells (p < 0.05, unpaired t test with Welch correction).
(B) Data are graphically presented with myeloid and B- and T-lymphoid lineage constituents (M-RU, B-RU, and T-RU).in Lnk-deficient HSCs is partly attributed to enhanced o
iB-lymphoid lineage expansion, but as shown in Figure
4, the contribution of T-lymphoid and myeloid RU is evi- s
ldent, implying that HSCs also are under the direct influ-
ence of Lnk deficiency. t
H
mSelf-Renewal Capacity of Single HSCs
Numbers of RU and CRU regenerated from single l
RCD34−KSL cells in BM of the recipient mice were esti-
mated by secondary transplantation as illustrated in t
sFigure 1. Six mice reconstituted with single wild-type
cells and two mice reconstituted with single Lnk-defi- o
cient cells were successfully analyzed, as shown in Ta-
ble 2. With wild-type HSCs, each CRU having a RU/cell C
cin a range of 0.28 to 3.26 gave rise to different numbers reased from 7.62 to 385 or from 3.38 to 872. The MAS
Table 2. Self-Renewal Activity in Single HSCs
Clones Primary Transplantation Secondary Transplantation
Donor BM Cells (×106)/ CRU/106
Mice No. RU/Cell Mouse RU/106 Cells RU/BM Cells CRU/BM MAS (RU/Cell)
WT 1 3.26 400 0.16 64 2.44 976 0.07
2 1.57 245 0.25 61 3.03 742 0.08
3 0.82 325 0.19 62 2.50 813 0.08
4 0.69 285 0.18 51 2.17 619 0.08
5 0.47 280 0.04 11 1.25 350 0.03
6 0.28 275 0.14 39 1.56 429 0.09
Lnk 1 7.62 385 1.00 385 2.50 963 0.40
KO 2 3.38 545 1.60 872 5.56 3030 0.29
The number of RU/cell was obtained from analysis of mice that were primary recipients of single CD34−KSL cells. The numbers of RU and
CRU/106 BM cells were obtained from analysis of mice that were secondary recipients of BM cells reconstituted with single CD34−KSL cells
(clones) from wild-type or Lnk-deficient mice. The number of BM cells in a primary recipient mouse (BM cells/mouse) was calculated based
on the minimal assumption that 20% of all BM cells are present in the femora and tibiae. The total numbers of secondary RU and CRU in BM
per mouse (RU/BM and CRU/BM) were obtained by calculation of (BM cells)(RU/106 cells)/106 and (BM cells)(CRU/106)/106. The MAS is the
number of RU divided by the number of CRU.f CRUs in a range of 350 to 976. As demonstrated
n Supplemental Figure S3, RU/cell and the number of
econdary CRUs regenerated were positively corre-
ated (p < 0.05). As a result, the numbers of RU/BM and
hose of CRU/BM exhibited linear correlation (p < 0.05).
owever, the numbers of RU/BM did not increase as
uch as did those of CRU/BM. Accordingly, the MAS
evels remained in a low and narrow range (0.03–0.09
U/cell), suggesting that RU/cell is determined by the
otal number of regenerated CRUs with relatively con-
tant MAS. These data indicate that RU/cell can be one
f the parameters of self-renewal capacity in HSCs.
On the other hand, with Lnk-deficient mice, each
RU produced 963 or 3030 CRUs, and the RU in-
Clonal Analysis of Normal and Lnk-Deficient HSCs
911levels remained at relatively higher levels (0.29 and
0.40). These data show that Lnk-deficient HSCs, partic-
ularly ones with high RUs, can maintain higher levels of
self-renewal activity than can wild-type HSCs.
Lnk Acts as a Negative Regulator in Presumptive
Self-Renewal Signaling
Since Lnk has been shown to be associated with c-Kit
(Takaki et al., 2002), we examined the effect of its li-
gand, KL, on in vitro self-renewal of HSCs. Varying con-
centrations of KL were tested on single CD34−KSL cells
in serum-free culture. The frequency of division and the
survival rate of Lnk-deficient CD34−KSL cells did not
significantly differ from those of wild-type CD34−KSL
cells (Supplemental Figure S4). Using an in vitro self-
renewal assay (Ema et al., 2000), we further examined
whether KL can modulate c-Kit signaling to induce self-
renewal division of Lnk-deficient CD34−KSL cells. As in
wild-type HSCs, KL was necessary for in vitro survival
of Lnk-deficient HSCs, but its signal alone was insuffi-
cient to promote their self-renewal (data not shown).
To elucidate the role of Lnk in self-renewal of HSCs,
we next cocultured 150 CD34−KSL cells with an OP-9
stromal cell line for 7 days in the absence of cytokines,
and then transferred one-fifteenth of the culture into le-
thally irradiated mice. As a control, one-fifteenth of 150
CD34−KSL cells freshly isolated from wild-type or Lnk-
deficient mice were transplanted into each of a group
of lethally irradiated mice along with 2 × 105 competi-
tor cells. Multilineage reconstitution was observed 3
months after transplantation in 9 of 9 mice transplanted
with wild-type cells and in 9 of 9 mice transplanted with
Lnk-deficient cells (Figure 5). After culture, only 1 of 9
mice that had received cultured wild-type cells showed
reconstitution with test donor cells. In contrast, 9 of 9
mice that had received cultured Lnk-deficient cellsFigure 5. In Vitro Maintenance of Lnk-Deficient HSCs
CD34−KSL cells (10-cell equivalent) from 8-week-old wild-type or
Lnk-deficient mice were transplanted into a group of lethally irradi-
ated mice along with 2 × 105 competitor cells (indicated as “Be-
fore”). Such cells were also cocultured with OP-9 cells for 7 days,
followed by transplantation (indicated as “After”). Recipient mice
were analyzed 3 months after transplantation. The mean of RU per
10 CD34−KSL cells from Lnk-deficient mice (5.04 ± 5.34, n = 9) was
significantly greater than that from wild-type mice (0.48 ± 0.32, n =
9) on Mann-Whitney testing (p = 0.0002). 1 of 9 mice that had re-
ceived cultured wild-type cells showed reconstitution with test do-
nor cells (0.04 RU/10 cells, n = 1). 9 of 9 mice that had received
cultured Lnk-deficient cells were reconstituted (3.40 ± 2.55 RU/10
cells, n = 9).were reconstituted. Since many CD34−KSL cells un-
derwent at least one cell division during culture, not
only survival but also self-renewal of HSCs should have
led to the in vitro maintenance of stem cell activity in
Lnk-deficient cells. These data together suggest that
under certain in vivo and in vitro conditions, the likeli-
hood of self-renewal of HSCs is increased when Lnk
is absent.
Discussion
Our newly established clonal assay revealed the great
diversity of repopulating activity in HSCs. While all my-
eloid, B-lymphoid, and T-lymphoid lineages were re-
constituted, the degrees of reconstitution in each lin-
eage varied (Figure 4). The proliferation capacity of
HSCs is thus dissociated from their multilineage differ-
entiation capacity. This heterogeneity of HSCs likely re-
sults from their different levels of self-renewal capacity.
Measurements of CRUs given by single HSCs, in fact,
suggest that the greater the self-renewal capacity, the
higher the repopulating activity (Table 2 and Supple-
mental Figure S3). It seems unlikely that HSCs with low
RU can regenerate themselves more than those with
high RU, but regenerated CRUs can be assumed to
maintain a high MAS level when HSCs have undergone
only a limited number of divisions. Heterogeneity in
self-renewal capacity by itself implies that HSC self-
renewal is not an unlimited capability.
Serial transplantation of BM cells has long been
known to lead to a decline of stem cell activity (Cud-
kowicz et al., 1964; Harrison and Astle, 1982; Hellman
et al., 1978; Ogden and Micklem, 1976; Sminovitch et
al., 1964). However, whether this is due to simple dilu-
tion or truly to exhaustion of stem cells by transplanta-
tion is still debated (Iscove and Nawa, 1997). This study
clearly demonstrates a clonal expansion of stem cell
activity and number (RUs and CRUs) after transplanta-
tion, supporting the notion of extensive self-renewal
capacity of HSCs (Iscove and Nawa, 1997; Pawliuk et
al., 1996). One might interpret these findings as indicat-
ing unlimited self-renewal capacity of HSCs when
either RU or CRU is examined (Iscove and Nawa, 1997).
However, when MAS is taken into account, it is clear
that the repopulating activity of regenerated stem cells
were significantly reduced versus that in originally
transplanted stem cells and that in normal BM cells (Ta-
ble 2). These data would explain why BM cells cannot
be serially transplanted in mice more than 4 to 6 times.
This study and the binomial model-based study by Har-
rison and his colleagues (Harrison et al., 1990) together
support the generation-age model (Rosendaal et al.,
1979), although lethally irradiated mice were used as
recipients in these experiments. Molecular mecha-
nisms responsible for this decline in repopulating ability
remain largely unknown. Telomeres shorten in HSCs af-
ter transplantation (Allsopp et al., 2003a). A decline in
RU seems positively correlated with telomere shorten-
ing (H.M. and H.N., unpublished data). It has been re-
ported that overexpression of telomerase can prevent
telomere shortening, yet it cannot prevent a decline in
stem cell activity (Allsopp et al., 2003b). Thus, unless
telomeres are critically short, telomere shortening itself
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912does not seem to be a limiting factor for repopulating p
ability of HSCs. Homing is another factor that could in- s
fluence repopulating ability of HSCs. However, it is s
uncertain whether homing is the only reason for poor I
repopulating activity in most HSCs regenerated in irra- f
diated mice. Further studies of Lnk-deficient mice may e
provide clues to the understanding of molecular mech- c
anisms involved in HSC homing. e
Previous studies showed increases of progenitor cell t
numbers in Lnk-deficient mice (Takaki et al., 2002; Vel-
azquez et al., 2002). The present study demonstrated p
that the absolute number of HSCs is also increased. In u
an attempt to clarify the mechanisms of HSC expansion a
in this mutant mouse, we quantified the repopulating N
activity in HSCs. The MAS of Lnk-deficient HSCs ap- i
peared significantly greater than that of wild-type HSCs e
by population-type analysis as well as by clonal analy- w
sis (Table 1 and Figure 4). Some Lnk-deficient HSCs f
regenerated a remarkably large number of HSCs after c
transplantation (Table 2). These results suggest that the
proliferation of HSCs in irradiated recipient mice is en- E
hanced by the lack of Lnk. Proliferative capacity should
Pbe directly associated with self-renewal events in
CHSCs. Of interest is that a single adaptor molecule, de-
d
spite the existence of a variety of such molecules, can a
play a critical role in signal transduction responsible for (
determination of HSC fate. p
fEnhanced homing ability may explain higher repopu-
slating ability in Lnk-deficient HSCs. Only Lnk-deficient
HSCs, and not wild-type ones, may home to “incom-
Cplete niches” that express very low levels of cognate
U
ligands. Alternatively, Lnk-deficient HSC may stay longer C
in niches, while maintaining self-renewal capacity, if w
their mobilization is restricted by highly expressed re- a
Gceptors that bind ligands in niches.
fIn single-cell transplantation experiments in which an
bindividual HSC was transplanted together with com-
mpetitor cells, the engraftment rate of Lnk-deficient
t
CD34−KSL cells did not differ from that of wild-type p
CD34−KSL cells. We at this moment interpret this result 2
as indicating that Lnk-deficient HSCs do not have an
tobvious advantage over wild-type ones in homing to
nthe stem cell niche in BM. Identification of specific
Lhoming receptors for HSCs, in combination with a solid
Lassay for HSC homing, would be needed to evaluate
i
these possibilities. c
The frequency of cell cycling in HSCs from Lnk-defi- t
cient mice seemed greater than that from wild-type
mice under physiological conditions (Supplemental R
TFigure S2). From the developmental point of view, the
aexponential increase in HSC number with Lnk defi-
cciency, as compared with wild-type, likely resulted from
fgreater probability of self-renewal in addition to ac- c
celerated cycling. We have not so far observed any dif- l
ferentiation block in Lnk-deficient HSCs, although it f
remains possible that reduced apoptosis of HSCs con- a
1tributes to their accumulation in Lnk-deficient mice.
nIn consideration of the more or less limited capacity
sof adult HSCs as shown in this study, several research-
(
ers have attempted to enhance HSC self-renewal ca-
pacity by using gain-of-function or loss-of-function C
approaches (Calvi et al., 2003; Reya et al., 2003; Sauva- C
geau et al., 1995; TeKippe et al., 2003; Varnum-Finney c
Bet al., 2000; Yuan et al., 2004; Zhang et al., 2003). Inarticular, overexpression of HoxB4 and Bmi-1 at the
tem cell level has recently been reported to induce
tem cell self-renewal in vitro (Antonchuk et al., 2002;
wama et al., 2004). RT-PCR analysis did not detect dif-
erences between wild-type and Lnk-deficient HSCs in
xpression level of these genes (data not shown). Be-
ause Lnk is a signal adaptor protein, we may need to
xamine HSCs after stimulation with certain ligands
hat induce signaling via interaction with Lnk.
Even without full understanding, however, Lnk can
erhaps be used as a tool to manipulate HSCs by
sing, for example, short-interfering RNAs (McManus
nd Sharp, 2002) or dominant-negative forms of Lnk.
evertheless, quantitative evaluation of how self-renewal
s attenuated at the clonal level by introduction of for-
ign genes or proteins into HSCs is important, because
e should know how manipulated HSCs are different
rom normal ones and to what extent self-renewal is
ontrollable in clinical settings.
xperimental Procedures
urification of HSCs
D34−KSL cells were purified from mouse BM cells as previously
escribed in detail (Ema et al., 2000; Osawa et al., 1996; Sudo et
l., 2000). Hoechst 33342 staining was performed as described
Goodell et al., 1996). In brief, lineage-depleted cells at 106 cells
er ml were stained with 5 g/ml of Hoechst 33342 (Sigma) at 37°C
or 90 min. After two washes, cells were subjected to antibody
taining while continuously maintained at 4°C.
ompetitive Repopulation Assay
nfractionated BM or purified CD34-KSL cells from 8-week-old
57BL/6 (B6)-Ly5.1 or Lnk-deficient B6-Ly5.2 mice were mixed
ith 2 × 105 BM cells from 8-week-old B6-Ly5.1/Ly5.2 (F1) mice
nd transplanted into a group of mice irradiated at a dose of 9.5
y. B6-Ly5.2 and B6-Ly5.1 mice were used as recipients for cells
rom B6-Ly5.1 and B6-Ly5.2 donor mice, respectively. Peripheral
lood cells of the recipient mice were taken between 3 and 4
onths after transplantation and analyzed on a FACS for reconsti-
ution in myeloid (Mac-1/Gr-1+), B-lymphoid (B220+), and T-lym-
hoid (CD4/CD8+) lineages as previously described (Ema et al.,
000; Sudo et al., 2000).
For secondary transplantation, recipient mice were sacrificed be-
ween 4 and 5 months after transplantation. Three or four different
umbers of BM cells reconstituted primarily with B6-Ly5.1 or B6-
y5.2 test donor cells were mixed with 2 × 105 BM cells from B6-
y5.2 or B6-Ly5.1 mice and transplanted into at least 10 lethally
rradiated B6-Ly5.2 or B6-Ly5.1 mice. F1-derived cells were ex-
luded upon reconstitution analysis 3–4 months after transplan-
ation.
U, CRU, and MAS
he percentage of chimerism was calculated based on FACS data
s follows: % chimerism = (% test donor cells) × 100/(% test donor
ells + % competitor cells). When % chimerism was more than 1.0
or all myeloid, B-lymphoid, and T-lymphoid lineages, test donor
ells were considered to contain at least one multilineage repopu-
ating cell. The number of RU in test donor cells was calculated as
ollows: RU = 2 × (% chimerism)/(100 − % chimerism) (Harrison et
l., 1993) or 2 × (% test donor cells)/(% competitor cells), as 2 ×
05 competitor cells were used. The frequency of CRUs in test do-
or cells was estimated by limiting-dilution assay as previously de-
cribed (Szilvassy et al., 1990). MAS has been defined as RU/CRU
RU/cell) (Ema and Nakauchi, 2000).
ell-Cycle Analysis
ell-cycle analysis was performed on 5000 or more CD34−KSL
ells isolated from 8-week-old wild-type or Lnk-deficient mouse
M, stained with propidium iodide (PI) as previously described
Clonal Analysis of Normal and Lnk-Deficient HSCs
913(Sudo et al., 2000). 5000 cells or more were fixed with 70% ethanol
in water, stained with 30 mg/ml of PI, and analyzed on a FACSCali-
bur. The methods of BrdU labeling and analysis are described in
Supplemental Data.
Coculture with OP-9 Cells
150 CD34−KSL cells from wild-type or Lnk-deficient mice were
mixed with 3 × 106 BM competitor cells. One-fifteenth of the aliquot
(equivalent to 10 CD34−KSL cells and 2 × 105 BM competitor cells)
was transplanted into each of a cohort of lethally irradiated mice.
In concurrent experiments, 150 CD34−KSL cells were directly
sorted onto a monolayer of OP-9 stromal cell line (Nakano et al.,
1996). Cells were incubated in 20% fetal calf serum in α-MEM at
37°C with 5% CO2 for 7 days. All adherent and nonadherent cells
were collected and mixed with 3 × 106 BM competitor cells. One-
fifteenth of the aliquot was transplanted into each of a cohort of
lethally irradiated mice. Recipient mice were analyzed 3 months
after transplantation.
RT-PCR Analysis
PCR analyses for Lnk and other genes were performed on normal-
ized cDNAs obtained from various hematopoietic cell populations
in wild-type or Lnk-deficient mice as previously described (Osawa
et al., 2000; Zhou et al., 2001).
Supplemental Data
Supplemental Data include four figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article
online at http://www.developmentalcell.com/cgi/content/full/8/6/
907/DC1/.
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